Dr Herbert Brinkman, based in Denver, Colorado, has over 30 years of experience in the pharmaceutical industry. Dr. Brinkman has prepared over 25 Chemistry Manufacturing and Control (CMC) sections and updates for multiple lnvestigational New Drug (IND), New Drug Application (NDA), supplementary NDA (sNDA), lnvestigational Medicinal Product Dossier (IMPDJ, and Abbreviated NDA
